Evidence map›Paper›PMID 40255823›Full record

ArticleCureus2025

Anaphylaxis-Associated Cerebral Infarction: A Case Report.

Tatsuya Watanabe, Hidetoshi Yamana, Koji Ishigami, Yusuke Tsutsumi, Noriyuki Kato

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatsuya WatanabeDepartment of Emergency Medicine, National Hospital Organization (NHO) Mito Medical Center, Ibaraki, JPN.
Hidetoshi YamanaDepartment of Emergency Medicine, National Hospital Organization (NHO) Mito Medical Center, Ibaraki, JPN.
Koji IshigamiDepartment of Emergency Medicine, National Hospital Organization (NHO) Mito Medical Center, Ibaraki, JPN.
Yusuke TsutsumiDepartment of Emergency Medicine, National Hospital Organization (NHO) Mito Medical Center, Ibaraki, JPN.
Noriyuki KatoDepartment of Emergency Medicine, National Hospital Organization (NHO) Mito Medical Center, Ibaraki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaphylaxis is a severe, potentially life-threatening allergic reaction that primarily affects the respiratory and cardiovascular systems. While neurological complications are rare, cerebral infarction may occur due to anaphylaxis-induced hypoperfusion, endothelial dysfunction, and a hypercoagulable state. The mechanisms underlying this association remain poorly understood, and reports of anaphylaxis-related stroke are scarce. A 75-year-old man with a history of diabetes mellitus and hypertension developed respiratory distress and loss of consciousness shortly after a bee sting. He was diagnosed with anaphylactic shock and treated with adrenaline, glucagon, and aggressive fluid therapy. Despite hemodynamic stabilization, he developed persistent left-dominant quadriplegia. Magnetic resonance imaging (MRI) revealed acute ischemic stroke confined to the cortical branches of the middle cerebral artery (MCA) bilaterally, with restricted diffusion on diffusion-weighted imaging (DWI) and decreased apparent diffusion coefficient (ADC) values. Magnetic resonance angiography demonstrated a signal void in the right MCA and stenosis of the left MCA. Perfusion-weighted imaging using time-to-maximum maps indicated prolonged transit time in the infarcted regions, which closely corresponded to the DWI lesions, suggesting that most of the hypoperfused tissue had already progressed to irreversible infarction. Given the extensive infarction and high risk of hemorrhagic transformation, single antiplatelet therapy was selected for secondary stroke prevention. While his neurological symptoms partially improved, he remained functionally dependent at discharge. Cerebral infarction is a rare but serious complication of anaphylaxis, especially in patients with underlying cerebrovascular risk factors. Early recognition of neurological deficits, prompt neuroimaging, and comprehensive hemodynamic stabilization are crucial in preventing irreversible brain ischemia. The underlying pathophysiology is thought to involve multiple mechanisms, including systemic hypotension, mast cell degranulation-induced endothelial dysfunction, transient or persistent cerebral vasoconstriction, and a hypercoagulable state triggered by inflammatory mediators. Considering the etiology of anaphylaxis-associated ischemic stroke is critical for guiding appropriate management strategies. This case highlights the importance of a multidisciplinary approach in managing anaphylaxis-related stroke. Further studies are warranted to clarify the pathophysiological mechanisms and develop tailored therapeutic strategies for this rare but severe condition.

Indexed as

acute cerebral infarctionanaphylaxisanti-platelet agentsbee-stingkounis syndromeperfusion weighted imaging(pwi)thrombolytic therapy

Identifiers

PMID40255823
PMCPMC12009058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.